Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of pro-inflammatory galectin-3 protein and sialic acid sugar deficiency in renal thrombosis
EF 2018-19
Résumé
Atypical hemolytic-uremic syndrome (aHUS) is a rare kidney disease caused by abnormal blood clots (thrombosis) in small blood vessels. About 1% of patients with respiratory infection by Streptococcus pneumoniae develop aHUS, known as pneumococcal-associated aHUS (P-HUS). There is currently no specific therapy for P-HUS due to our poor understanding of its pathobiology. The only clue we have is that these patients have high blood levels of pneumococcal sialidase, an enzyme that cleaves terminal sialic acid from glycoproteins. We previously identified loss-of-function mutations in the gene ST3Gal1 in 3 patients with aHUS. ST3Gal1 is a sialyltransferase that adds terminal sialic acid sugar to galactose residues on glycoproteins. St3gal1-null mice and rats had increased asialoglycoproteins (absence of terminal sialic acid) in the glomeruli of the kidney. The same results were observed with addition of exogenous sialidase. We recently found that glomeruli of St3gal1-null rats had high levels of galectin-3 and control animals did not. Galectin-3 is a pro-inflammatory protein that binds terminal galactose: it would therefore be expected to bind to asialoglycoproteins. We do not know if galectin-3 interacts with asialoglycoproteins or whether it plays a role in the pro-thrombotic process experienced by patients. We hypothesize that the interaction between galectin-3 and glomerular asialoglycoproteins is critical to promote renal thrombosis in ST3Gal1 deficiency and P-HUS. We will investigate by first determining where galectin-3 is expressed in glomeruli, using various glomerular endothelial and immune cell markers. Our work will contribute to the understanding of P-HUS pathobiology for development of treatments of this rare, detrimental disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
411246
Name
Hossain Lamia F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of pro-inflammatory galectin-3 protein and sialic acid sugar deficiency in renal thrombosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Sialidase; Galectin-3; Glycoprotein; Kidney Disease; Pneumococcal-Associated Hus; Renal Thrombosis; Sialic Acid; St3gal1; Streptococcus Pneumoniae
Abstract
Atypical hemolytic-uremic syndrome (aHUS) is a rare kidney disease caused by abnormal blood clots (thrombosis) in small blood vessels. About 1% of patients with respiratory infection by Streptococcus pneumoniae develop aHUS, known as pneumococcal-associated aHUS (P-HUS). There is currently no specific therapy for P-HUS due to our poor understanding of its pathobiology. The only clue we have is that these patients have high blood levels of pneumococcal sialidase, an enzyme that cleaves terminal sialic acid from glycoproteins. We previously identified loss-of-function mutations in the gene ST3Gal1 in 3 patients with aHUS. ST3Gal1 is a sialyltransferase that adds terminal sialic acid sugar to galactose residues on glycoproteins. St3gal1-null mice and rats had increased asialoglycoproteins (absence of terminal sialic acid) in the glomeruli of the kidney. The same results were observed with addition of exogenous sialidase. We recently found that glomeruli of St3gal1-null rats had high levels of galectin-3 and control animals did not. Galectin-3 is a pro-inflammatory protein that binds terminal galactose: it would therefore be expected to bind to asialoglycoproteins. We do not know if galectin-3 interacts with asialoglycoproteins or whether it plays a role in the pro-thrombotic process experienced by patients. We hypothesize that the interaction between galectin-3 and glomerular asialoglycoproteins is critical to promote renal thrombosis in ST3Gal1 deficiency and P-HUS. We will investigate by first determining where galectin-3 is expressed in glomeruli, using various glomerular endothelial and immune cell markers. Our work will contribute to the understanding of P-HUS pathobiology for development of treatments of this rare, detrimental disease.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hossain, Lamia F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~